Dabigatran vs Erlotinib

## Dabigatran vs Erlotinib: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Erlotinib**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Erlotinib — 36 hours.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Erlotinib — C22H23N3O4.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Erlotinib — 393.4380 g/mol.

**Type**: Dabigatran — Small molecule; Erlotinib — Small molecule.